Bence Daniel

23PUBLICATIONS

219CO-AUTHORS

Predictive and prognostic markersPharmacogenomicsMolecular targetsInnate immunityGene expression (incl. microarray and other genome-wide approaches)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jul 06, 2026

Promoter reinforcement supports transcriptional resilience in drug-resistant cancer.

|May 04, 2026

Phosphorylated ubiquitin is a secondary messenger and an epigenetic mark mediating mitochondria to nucleus signaling.

|Mar 31, 2026

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER<sup>+</sup> HER2<sup>-</sup> locally-advanced or metastatic breast cancer.

Jackson Liang, Christy Ong, Kareem Heslop

|Jan 14, 2026

A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

Phillip Thienger, Irene Paassen, Xiaosai Yao

|Aug 08, 2025

Clonal lineage tracing of innate immune cells in human cancer.

Vincent Liu, Katalin Sandor, Patrick K Yan

|Aug 02, 2025

Epiregulon: Single-cell transcription factor activity inference to predict drug response and drivers of cell states.

Tomasz Włodarczyk, Aaron Lun, Diana Wu

Pageof 4

Frequent Collaborators

14 joint publications

Ansuman T Satpathy

Katalin Sandor

Caleb Lareau

Julia Belk

Evan W Weber

Elena Sotillo

Howard Y Chang

Dorota Klysz

Patrick J Quinn

Robbie G Majzner

Frequent Collaborators

14 joint publications

Ansuman T Satpathy

9 joint publications

Katalin Sandor

5 joint publications

Caleb Lareau

5 joint publications

Julia Belk